首页 | 本学科首页   官方微博 | 高级检索  
     

青蒿素对恶性疟配子体感染性的影响
引用本文:陈沛泉,李国桥,郭兴伯,何坤荣,符永新,符林春,宋玉宗. 青蒿素对恶性疟配子体感染性的影响[J]. 中华医学杂志, 1994, 0(4)
作者姓名:陈沛泉  李国桥  郭兴伯  何坤荣  符永新  符林春  宋玉宗
作者单位:广州中医学院三亚热带医学研究所
摘    要:将27例携带恶性疟配子体的患者,分为A、B、C3组,A组日服青蒿素1200mg共5天,B组顿服甲氟喹750mg,C组顿服甲氟喹750mg+伯氨喹45mg。服药后按计划逐日取血观察配子体密度变化,同时观察配子体对大劣按蚊的感染情况。结果显示:A组服药后4、7、14和2l天配子体密度和按蚊感染率下降非常显著,7天以后配子体感染性明显下降;B组7、14和21天配子体密度显著减少,14天和2l天配子体感染性和按蚊感染率下降非常明显;C组9例4天时有5例配子体消失,全部不能感染蚊媒。说明青蒿素对恶性疟配子体感染性有抑制作用,在阻断恶性疟传播途径方面的作用明显优于甲氟喹。

关 键 词:疟疾,青蒿素,恶性疟原虫

The infectivity of gametocytes of plasmodiumfalciparum from patients treated with artemisinin
ChenPeiquan, Li Guoqiao, Guo Hingbo,et al.. The infectivity of gametocytes of plasmodiumfalciparum from patients treated with artemisinin[J]. Zhonghua yi xue za zhi, 1994, 0(4)
Authors:ChenPeiquan   Li Guoqiao   Guo Hingbo  et al.
Affiliation:ChenPeiquan, Li Guoqiao, Guo Hingbo, et al.
Abstract:7 patients with gametocytes of P. .falciparumwere divided into groups A, B and C. 1200 mg ofartemisinin was given as a daily dose for 5 days togroup A, 750 mg of mefloquine as a single dose togroup B, and 750 mg of mefloquine plus 45 mg ofprimaquine as a single dose to group C. Aftermedication, gametocyte count was observed daily inaddition to the infectivity of gametocytes of P.falciparum to Anopheles dirus. In group A, the densityof gametocytes and the infectivity were significantlyreduced on days 4,7,14 and 21 during the study. Ingroup B, the density of gametocytes was significantlyreduced on days 7, 14 and 21 and the infectivity wasobviously lowered on days 14 and 21 after medication.In group C, gametocytes disappeared in 5 out of 9 pa-tients with the failure of infection to mosquitoes onday 4 after treatment. This indicates that artemisinincan effectively influence the infectivity of gametocytesof P. falciparum. Artemisinin is superior to mefloquinein blocking the transmission of P. falciparum malaria.
Keywords:Artemisinin GametocytePlasmodium falciparum Infectivity Anophelesdirus  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号